https://www.indianpharmapost.com/fda-grants-breakthrough-status-to-lagunas-mrna-blood-test-for-schizophrenia-diagnosis-200222026-05-02T00:00:00+05:30always0.9https://www.indianpharmapost.com/dr-lal-pathlabs-posts-strong-q4-fy26-results-with-166-revenue-growth-pat-at-rs-132-cr-200312026-05-02T00:00:00+05:30always0.9https://www.indianpharmapost.com/indoco-remedies-to-exit-ophthalmic-business-in-strategic-sale-to-sunways-india-200302026-05-02T00:00:00+05:30always0.9https://www.indianpharmapost.com/merck-posts-mixed-q1-2026-results-as-blockbuster-drugs-drive-growth-200292026-05-02T00:00:00+05:30always0.9https://www.indianpharmapost.com/thermo-fisher-to-sell-microbiology-business-in-1075-billion-deal-with-astorg-200282026-05-02T00:00:00+05:30always0.9https://www.indianpharmapost.com/thermo-fisher-opens-flagship-us-bioprocess-design-center-in-massachusetts-200272026-05-02T00:00:00+05:30always0.9https://www.indianpharmapost.com/gilead-completes-78b-arcellx-acquisition-takes-full-control-of-myeloma-car-t-candidate-200262026-05-02T00:00:00+05:30always0.9https://www.indianpharmapost.com/imcd-posts-steady-q1-2026-performance-with-130-million-ebita-amid-global-uncertainty-200252026-05-02T00:00:00+05:30always0.9https://www.indianpharmapost.com/bayer-pushes-stroke-prevention-drug-forward-in-china-as-regulators-accept-key-filing-200242026-05-02T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-renews-iqos-reduced-risk-status-backing-pmis-smoke-free-strategy-in-regulatory-win-200232026-05-02T00:00:00+05:30always0.9https://www.indianpharmapost.com/aster-dm-healthcare-surges-in-q4-200322026-05-02T00:00:00+05:30always0.9